Skip to content
  • Saturday, 15 August 2026
  • 5:01 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Johns Hopkins Study Reveals Significant Heart Tissue Weakening and Arrhythmia Risk in Low Gravity Environments
Stem Cell & Regenerative Medicine

Johns Hopkins Study Reveals Significant Heart Tissue Weakening and Arrhythmia Risk in Low Gravity Environments

Dwi Wanna Jun 2, 2026 0

In a landmark study that underscores the biological challenges of long-duration space exploration, scientists at Johns Hopkins Medicine have found…

Read More
Environmental & Analytical Chemistry

A key ocean current that warms Europe is weakening, spurring a controversial megadam proposal

Abdurrohim Arsyad May 28, 2026 0

The Atlantic Meridional Overturning Circulation, commonly known as the AMOC, a vast system of ocean currents that plays a critical…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Study Reveals Significant Cardiac Weakening and Molecular Changes in Bioengineered Heart Tissues After Month Long Space Station Mission

Dwi Wanna May 11, 2026 0

The biological toll of long-duration spaceflight has long been a concern for space agencies worldwide, but new research from Johns…

Read More
Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.Probiotic Yogurt Strain May Boost Immunotherapy Response in Lung Cancer, Small Study SuggestsBioNTech Pivots Dramatically to Oncology Amidst Waning Vaccine Revenue and Federal Shift, Cutting 1,860 Jobs and Investing €16.8 Billion in CashBiogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ